- Home
- ANGO vs JUNS Comparison
ANGO vs JUNS Comparison
Compare ANGO & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- JUNS
- Stock Information
- Founded
- ANGO 1988
- JUNS 2015
- Country
- ANGO United States
- JUNS United States
- Employees
- ANGO N/A
- JUNS N/A
- Industry
- ANGO Medical/Dental Instruments
- JUNS
- Sector
- ANGO Health Care
- JUNS
- Exchange
- ANGO Nasdaq
- JUNS NYSE
- Market Cap
- ANGO 401.4M
- JUNS 281.4M
- IPO Year
- ANGO 2004
- JUNS 2024
- Fundamental
- Price
- ANGO $10.08
- JUNS $0.75
- Analyst Decision
- ANGO Strong Buy
- JUNS
- Analyst Count
- ANGO 3
- JUNS 0
- Target Price
- ANGO $13.00
- JUNS N/A
- AVG Volume (30 Days)
- ANGO 552.5K
- JUNS 149.3K
- Earning Date
- ANGO 04-02-2025
- JUNS 05-11-2025
- Dividend Yield
- ANGO N/A
- JUNS N/A
- EPS Growth
- ANGO N/A
- JUNS N/A
- EPS
- ANGO N/A
- JUNS N/A
- Revenue
- ANGO $286,498,000.00
- JUNS N/A
- Revenue This Year
- ANGO N/A
- JUNS N/A
- Revenue Next Year
- ANGO $6.63
- JUNS N/A
- P/E Ratio
- ANGO N/A
- JUNS N/A
- Revenue Growth
- ANGO N/A
- JUNS N/A
- 52 Week Low
- ANGO $5.26
- JUNS $0.55
- 52 Week High
- ANGO $13.50
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- ANGO 54.84
- JUNS N/A
- Support Level
- ANGO $9.34
- JUNS N/A
- Resistance Level
- ANGO $9.84
- JUNS N/A
- Average True Range (ATR)
- ANGO 0.45
- JUNS 0.00
- MACD
- ANGO 0.15
- JUNS 0.00
- Stochastic Oscillator
- ANGO 96.79
- JUNS 0.00
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.